BidaskClub cut shares of DENTSPLY SIRONA (NASDAQ:XRAY) from a buy rating to a hold rating in a research report report published on Friday morning.
A number of other equities research analysts have also recently commented on the stock. UBS Group initiated coverage on shares of DENTSPLY SIRONA in a report on Thursday, January 17th. They issued a neutral rating and a $42.00 price target on the stock. William Blair raised shares of DENTSPLY SIRONA from a market perform rating to an outperform rating in a report on Friday, March 1st. Zacks Investment Research raised shares of DENTSPLY SIRONA from a strong sell rating to a hold rating in a report on Sunday, January 6th. Robert W. Baird lifted their price target on shares of DENTSPLY SIRONA from $42.00 to $50.00 and gave the stock a neutral rating in a report on Monday, March 4th. Finally, Barclays reaffirmed a hold rating and issued a $39.00 price target on shares of DENTSPLY SIRONA in a report on Sunday, January 6th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and seven have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of Hold and a consensus price target of $52.12.
NASDAQ:XRAY opened at $49.33 on Friday. The company has a current ratio of 1.86, a quick ratio of 1.27 and a debt-to-equity ratio of 0.30. The company has a market capitalization of $10.96 billion, a P/E ratio of 24.54, a P/E/G ratio of 2.21 and a beta of 1.08. DENTSPLY SIRONA has a 12 month low of $33.93 and a 12 month high of $51.97.
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 12th. Shareholders of record on Friday, March 29th will be issued a dividend of $0.087 per share. The ex-dividend date of this dividend is Thursday, March 28th. This represents a $0.35 dividend on an annualized basis and a yield of 0.71%. DENTSPLY SIRONA’s payout ratio is 17.41%.
Hedge funds have recently modified their holdings of the business. Harel Insurance Investments & Financial Services Ltd. bought a new stake in DENTSPLY SIRONA during the 4th quarter valued at $26,000. Private Capital Group LLC raised its holdings in DENTSPLY SIRONA by 105.3% during the 4th quarter. Private Capital Group LLC now owns 700 shares of the medical instruments supplier’s stock valued at $26,000 after acquiring an additional 359 shares during the period. Pinnacle Bank bought a new stake in DENTSPLY SIRONA during the 4th quarter valued at $26,000. Truehand Inc bought a new stake in DENTSPLY SIRONA during the 4th quarter valued at $27,000. Finally, Enlightenment Research LLC bought a new stake in DENTSPLY SIRONA during the 4th quarter valued at $30,000. 96.30% of the stock is currently owned by institutional investors and hedge funds.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Read More: What is a Roth IRA?
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.